We are live on ! Find out more
TBRA

Tobira Therapeutics, Inc. Common Stock
TBRA

Delisted

TBRA was delisted on the 31st of October, 2016.

46 hedge funds and large institutions have $91.7M invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

4% less funds holding

Funds holding: 4846 (-2)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

23% less capital invested

Capital invested by funds: $120M → $91.7M (-$28M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.23%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
2
Increased
16
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$66K +$1.86K +247 +3%
TCIM
27
TIAA CREF Investment Management
New York
$53K
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$46K +$6.27K +831 +17%
BA
29
BlackRock Advisors
Delaware
$37K -$52.1K -6,903 -60%
TA
30
Teachers Advisors
New York
$31K
Deutsche Bank
31
Deutsche Bank
Germany
$30K -$21.6K -2,862 -43%
JP Morgan Chase
32
JP Morgan Chase
New York
$25K +$22.8K +3,025 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$18K
Citigroup
34
Citigroup
New York
$15K +$13.7K +1,819 +9,574%
BJ
35
BlackRock Japan
Japan
$14K +$2.97K +394 +29%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$13K +$11K +1,461 +1,259%
AIG
37
American International Group
New York
$12K
Bank of America
38
Bank of America
North Carolina
$11K -$468 -62 -5%
NFA
39
Nationwide Fund Advisors
Ohio
$10K
TRCT
40
Tower Research Capital (TRC)
New York
$8K -$1.18K -156 -13%
SO
41
STRS Ohio
Ohio
$4K
CSS
42
Cubist Systematic Strategies
Connecticut
$2K -$9.64K -1,278 -86%
Wells Fargo
43
Wells Fargo
California
$2K +$1.86K +247 +1,074%
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$1K +$15 +2 +3%
Geode Capital Management
45
Geode Capital Management
Massachusetts
$263 +$6.03K +799 +3%
TC
46
TFS Capital
Pennsylvania
-$406K -40,384 Closed
SIM
47
Spark Investment Management
New York
-$207K -20,670 Closed
UBS Group
48
UBS Group
Switzerland
-$25K -2,504 Closed
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
-$4.94K -492 Closed

TBRA Hedge Fund Activity: Q1 2016 in Review

46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q1 2016, worth a combined $91.7M — down 23% from $120M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TBRA and 2 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 16 added.

The largest buyer was Franklin Resources, opening a new position worth an estimated $4.42M. The largest seller was Sabby Management, cutting an estimated $5.86M.

  • 46 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q1 2016, down from 48 in Q4 2015.
  • Funds reported $91.7M of Tobira Therapeutics, Inc. Common Stock stock for Q1 2016, down 23% quarter-over-quarter.
  • 2 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q1 2016 and 4 closed out, a net change of -2 holders.
  • The largest Tobira Therapeutics, Inc. Common Stock buyer in Q1 2016 was Franklin Resources, an estimated $4.42M added.
  • The largest Tobira Therapeutics, Inc. Common Stock seller in Q1 2016 was Sabby Management, an estimated $5.86M sold.

Based on aggregated 13F filings for Q1 2016.